Cases 1 - 10 of 35
Supernus Pharmaceuticals, Inc. v. Alkem Laboratories Ltd.
as 1:2022cv03511
Plaintiff:
Supernus Pharmaceuticals, Inc.
Defendant:
Alkem Laboratories Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Ingenus Pharmaceuticals, LLC et al v. Nexus Pharmaceuticals, Inc.
as 1:2022cv02868
Plaintiff:
Ingenus Pharmaceuticals, LLC and Leiutis Pharmaceuticals LLP
Defendant:
Nexus Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Melinta Therapeutics, LLC et al v. Nexus Pharmaceuticals, Inc.
as 1:2021cv05995
Plaintiff:
MELINTA THERAPEUTICS, LLC, Melinta Subsidiary Corp. and Rempex Pharmaceuticals, Inc.
Defendant:
Nexus pharmaceuticals, Inc., PHV IMRON T. ALY, PHV JOEL M. WALLACE and others
Cause Of Action: 35 U.S.C. § 271
Melinta Therapeutics, LLC et al v. Nexus Pharmaceuticals, Inc.
as 1:2021cv02636
Plaintiff:
Melinta Subsidiary Corp., Rempex Pharmaceuticals, Inc. and Melinta Therapeutics, LLC
Defendant:
Nexus Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Medicure International, Inc. v. Nexus Pharmaceuticals, Inc.
as 1:2019cv07979
Plaintiff:
Medicure International, Inc.
Defendant:
Nexus Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Aurobindo Pharmaceuticals Limited et al v. Daiici Sankyo, Inc. et al
as 1:2016cv04876
Plaintiff:
Aurobindo Pharmaceuticals Limited and Aurobindo Pharma, Inc.
Defendant:
Daiici Sankyo, Inc. and Daiichi Sankyo Co., Ltd.,
Intervenor_defendant:
Mylan Pharmaceuticals Inc.
Objector:
Alembic Pharmaceuticals limited
Cause Of Action: 35 U.S.C. § 271
The Medicines Company v. Sagent Pharmaceuticals, Inc.
as 1:2015cv07507
Plaintiff:
The Medicines Company
Defendant:
Sagent Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Baxter Healthcare Corporation et al v. Sagent Pharmaceuticals Inc.
as 1:2015cv02076
Plaintiff:
Baxter Healthcare Corporation , Baxter International Inc. and Baxter Healthcare S.A.
Defendant:
Sagent Pharmaceuticals Inc.
Cause Of Action: 15 U.S.C. § 1126
ABBVIE INC. et al v. MYLAN PHARMACEUTICALS INC. et al
as 1:2015cv01402
Plaintiff:
ABBVIE INC. and ABBVIE DEUTSCHLAND GMBH & CO. KG
Defendant:
MYLAN PHARMACEUTICALS INC. , MYLAN LABORATORIES LTD. , MYLAN LABORATORIES INC. and others
Counter_claimant:
MYLAN INC. , MYLAN LABORATORIES LTD. , MYLAN PHARMACEUTICALS INC. and others
Counter_defendant:
ABBVIE DEUTSCHLAND GMBH & CO. KG and ABBVIE INC.
Cause Of Action: 28 U.S.C. § 1331
AstraZeneca Pharmaceuticals LP et al v. Sagent Pharmaceuticals, Inc.
as 1:2014cv07358
Plaintiff:
AstraZeneca Pharmaceuticals LP , AstraZeneca UK Limited and AstraZeneca AB
Defendant:
Sagent Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
